Atopic Dermatitis
Glenmark receives FDA approval for generic atopic dermatitis cream
Baricitinib meets primary endpoint in adults with atopic dermatitis
Should providers recommend bleach baths without conclusive evidence of their benefits?
According to research published in Trends in Microbiology, patients with atopic dermatitis, or AD, are commonly colonized with Staphylococcus aureus during flares. Bleach baths are one way clinicians are trying to reduce S. aureus colonization in AD patients and subsequently reduce disease severity.
New medications ‘revolutionary’ for kids with atopic dermatitis
Atopic dermatitis, one of the most common inflammatory skin conditions, begins in many patients by age 1 year, according to the American Academy of Dermatology. Globally, an estimated one in five children is affected by the disease. The prevalence is higher among children in developed countries, including the United States, and it may be increasing, researchers suggest.
Long-term dupilumab treatment safe, effective for atopic dermatitis
Psoriasis resource, guidelines top dermatology stories this week
Dupixent shows positive results in children with severe atopic dermatitis
Filaggrin gene loss-of-function variants differ by race in children with atopic dermatitis
Therapeutic drugs on the horizon in atopic dermatitis
NEW YORK — There are now multiple target treatments to utilize in patients with atopic dermatitis, but there is still a very large unmet need for better treatment in this disease, according to Emma Guttman-Yassky, MD, PhD, a Sol and Clara Kest professor of dermatology at Icahn School of Medicine at Mount Sinai in New York.